210 related articles for article (PubMed ID: 12813160)
1. Simulated screening for prostate cancer: the useful model.
Church TR
J Natl Cancer Inst; 2003 Jun; 95(12):838-9. PubMed ID: 12813160
[No Abstract] [Full Text] [Related]
2. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
3. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.
Boyle P
Ann Oncol; 1998 Dec; 9(12):1263-4. PubMed ID: 9932152
[No Abstract] [Full Text] [Related]
4. The science and art of prostate cancer screening.
Yao SL; Lu-Yao GL
J Natl Cancer Inst; 2011 Mar; 103(6):450-1. PubMed ID: 21350220
[No Abstract] [Full Text] [Related]
5. Risks of PSA screening now better understood.
Peres J
J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
[No Abstract] [Full Text] [Related]
6. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
7. Screening for prostate cancer - will we ever know?
Adolfsson J
Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
[No Abstract] [Full Text] [Related]
8. Prostate specific antigen and screening for early prostate cancer.
Davidson P
N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
[No Abstract] [Full Text] [Related]
9. [Is the mass screening for prostate cancer justifiable?].
Döbrossy L; Kovács A; Budai A; Cornides A
Orv Hetil; 2007 Jul; 148(26):1213-6. PubMed ID: 17588854
[TBL] [Abstract][Full Text] [Related]
10. [In depth analysis of 2 studies of prostate cancer screening--what makes sense?].
Recker F
Praxis (Bern 1994); 2010 Feb; 99(3):183-5. PubMed ID: 20127638
[No Abstract] [Full Text] [Related]
11. Prostate cancer screening.
Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703
[No Abstract] [Full Text] [Related]
12. Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.
Wilt TJ; Scardino PT; Carlsson SV; Basch E
J Natl Cancer Inst; 2014 Mar; 106(3):dju010. PubMed ID: 24594482
[No Abstract] [Full Text] [Related]
13. Lest we abandon digital rectal examination as a screening test for prostate cancer.
Basler JW; Thompson IM
J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
[No Abstract] [Full Text] [Related]
14. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
15. Prostate Cancer Screening and the Associated Controversy.
Tabayoyong W; Abouassaly R
Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: 4. Screening.
Meyer F; Fradet Y
CMAJ; 1998 Oct; 159(8):968-72. PubMed ID: 9834724
[No Abstract] [Full Text] [Related]
17. Studies of prostate-cancer mortality: caution advised.
Etzioni R; Feuer E
Lancet Oncol; 2008 May; 9(5):407-9. PubMed ID: 18452850
[No Abstract] [Full Text] [Related]
18. Update on urology--prostate cancer. Screening for prostate cancer: an European view.
de Silva FC
Eur J Surg Oncol; 1996 Apr; 22(2):189-91, 196. PubMed ID: 8608840
[No Abstract] [Full Text] [Related]
19. The prostate cancer conundrum.
Albertsen PC
J Natl Cancer Inst; 2003 Jul; 95(13):930-1. PubMed ID: 12837821
[No Abstract] [Full Text] [Related]
20. Prostatic cancer: hospital-based prostate specific antigen screening.
Vogl M; Müller MM; Höltl W
Clin Biochem; 1997 Jun; 30(4):357-60. PubMed ID: 9209795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
